C. Schechter

Cost Effectiveness of Cervical Cancer Screening for the Elderly

M. Fahs, J. Mandelblatt, C. Schechter, 1992, Annals of Internal Medicine.

Cost-effective analysis of mechanical thrombectomy (MT) in patients with poor baseline modified Rankin Score (mRS)

C. Schechter, D. Altschul, S. Lee, 2022, Journal of Clinical Neuroscience.

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

C. Isaacs, J. Mandelblatt, C. Schechter, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.

James M. Hodge, Jack A. Taylor, E. Burnside, 2022, JAMA oncology.

EFFECTIVE INHIBITION OF THYROID ANTIGEN PRESENTATION USING RETRO-INVERSO PEPTIDES IN EXPERIMENTAL AUTOIMMUNE THYROIDITIS: A PATHWAY TOWARDS IMMUNE THERAPIES OF THYROID AUTOIMMUNITY.

R. Osman, C. Schechter, Y. Tomer, 2023, Thyroid : official journal of the American Thyroid Association.

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics

C. Isaacs, J. Mandelblatt, C. Schechter, 2021, Cancer medicine.

Clinical implications of screening for cervical cancer under Medicare. The natural history of cervical cancer in the elderly: what do we know? What do we need to know?

M. Fahs, J. Mandelblatt, C. Schechter, 1991, American journal of obstetrics and gynecology.

Permanent hypothyroidism following immune checkpoint inhibitors induced thyroiditis may be associated with improved survival: results of an exploratory study

C. Schechter, Y. Tomer, Hanna J Lee, 2023, Frontiers in Endocrinology.

Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in U.S. women, 2000-2017.

Jennifer L. Caswell-Jin, D. Berry, S. Plevritis, 2022, Journal of Clinical Oncology.

Analysis of Breast Cancer Mortality in the US-1975 to 2019.

Jennifer L. Caswell-Jin, A. Trentham-Dietz, J. Mandelblatt, 2024, JAMA.